Category : Clinical Trials Trends

5 Challenges Pharma Faces in this Tech Revolution

Pharmaceutical companies face challenges in this tech revolution

The rise of digital technology solutions has had a significant impact on every industry, and pharma is no exception. Even if you feel like you’re a bit behind, you’ve heard how new solutions like this are being used to improve recruitment and engagement rates in clinical trials while red

eDRO: the Future of Data Collection in Clinical Trials?

Mobile health development crucial to using eDROs in clinical trials

Advancement in mHealth technology means a growing list of methods that we can use to collect data during clinical trials. The rise of electronic patient reported outcomes (ePRO) has changed the way sponsors and biopharmaceutical companies prefer to collect data from patients. Studies have shown just

Should You Use Quantitative Modeling for Your Clinical Trial?

Researchers use a quantitative model in their clinical trial

As large scale clinical trials become more complex, the benefits of quantitative modeling (“modeling and simulation (M&S)”) have become more apparent. Essentially, these methods utilize big data and computer algorithms to predict certain aspects of future studies. Quantitative modeling has the p

Is It Time to Modernize Clinical Trial Eligibility?

Clinical investigators believe that clinical trial eligibility may be too strict

Did you know that only five percent of adult cancer patients participate in a clinical trial in any given year? Despite constantly redoubling efforts and improving upon recruitment strategies, this number has not budged throughout the decades. In recent years, specific collaborations have: Made enga

2 Key Changes That’ll Improve Mental Health Clinical Trials

Patient in mental health clinical trial works on puzzle

Mental health issues have a growing impact on our society, but there appears to be a disparity between how public policies address mental illness compared to other medical conditions like diabetes, cancer, and heart disease. One in five American adults experiences mental illness in a given year, amo

Will Transportation to Clinical Trials Hinder Participation in 2017?

Lyft driver takes patient to their clinical trial

At the risk of sounding like a broken record, one of the biggest challenges in our industry is getting enough patients to participate in a trial. Although the general public seems to understand that volunteers play a pivotal role in our efforts, they aren’t exactly lining up in the streets for a spo

How Do We Improve Patient Centricity in 2017?

Researcher considers how to improve patient centricity in his clinical studies

Patient centricity has become a buzzword in this industry, but that doesn’t mean we’ve gotten it right yet. While many have invested time and resources in patient centric design, the industry as a whole still has a long way to go. Based on reported enrollment and retention rates in studi

Should We Share Clinical Trial Data with Patients?

Clinical researcher discusses study results with study participant

We continually search for ways to make clinical trials more patient-centric. Since clinical research volunteers are the foundation of our industry, getting them enrolled, keeping them engaged, and facilitating an excellent experience are crucial. In an effort to improve patient centricity, we’ve see

How New Virtual Clinical Trials Have Improved Patient Recruitment

Man enrolls in a virtual clinical trial via his iPad

In 2011, Pfizer conducted what has come to be known as the first virtual clinical trial. It was revolutionary project, allowing sites to manage participants through electronic devices and patients to participate from wherever they lived. There was just one problem… it didn’t recruit! While the

eSource: Why It’s Time to Invest in a Better Solution

Clinical investigator using eSource to monitor study data

The process of clinical research is extensive and extremely expensive. If we consider traditional models, a lot of this expense (in time and money) can be attributed to data collection. Novartis conducted a study on their paper-based clinical trials and found that printing costs could run up to $50,